Online Program

Population –level physical inactivity and the cost of obesity

Tuesday, November 5, 2013 : 1:10 p.m. - 1:30 p.m.

Loretta DiPietro, PhD, MPH, Department of Exercise Science, The George Washington University, School of Public Health and Health Services, Washington, DC
The purpose of this presentation is to propose global population levels of physical inactivity as our greatest public health challenge with regard to the economic burden of obesity. Trend data of lifestyle changes over the last several decades, along with corresponding data on obesity and diabetes prevalence will be provided, along with data comparing the economic, physical, psychological, and societal impact of preventing versus treating obesity. The talk will finish by describing specific systems-level approaches and policy recommendations that can begin to ameliorate the burdens associated with obesity.

Learning Areas:

Chronic disease management and prevention
Implementation of health education strategies, interventions and programs
Public health or related public policy
Systems thinking models (conceptual and theoretical models), applications related to public health

Learning Objectives:
Define the role of lifestyle inactivity in obesity etiology; List 3 lifestyle changes that have influenced the population prevalence of obesity; Compare and contrast the costs of preventing versus treating obesity; List one systems approach or policy recommendation to address obesity at the population level.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have been studying the relationship between physical activity, obesity, and metabolic disease for over 25 years at the population- and the laboratory-levels. Moreover, I have been the principal investigator or co-investigator on multiple federally-funded grants focusing on these topics. Among my current interests is the relation between sedentary lifestyle, excess adiposity, and measures of metabolic inflexibility in older people at risk for type 2 diabetes.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.